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Abstract: Nuclear magnetic resonance (NMR) spectroscopy is one of the most promising methods
for use in metabolomics studies as it is able to perform non targeted measurement of metabolites
in a quantitative and non-destructive way. Sample preparation of liquid samples like urine or
blood serum is comparatively easy in NMR metabolomics, because mainly buffer and chemical shift
reference substance are added. For solid samples like feces suitable extraction protocols need to be
defined as initial step, where the exact protocol depends on sample type and features. Focusing on
short chain fatty acids (SCFAs) in mice feces, we describe here a set of extraction protocols developed
with the aim to suppress changes in metabolite composition within 24 h after extraction. Feces are
obtained from mice fed on either standard rodent diet or high fat diet. The protocols presented in
this manuscript are straightforward for application, and successfully minimize residual bacterial
and enzymatic activities. Additionally, they are able to minimize the lipid background originating
from the high fat diet.
Keywords: metabolomics; mice; feces; faeces; NMR spectroscopy; short chain fatty acids; dietary
fibers; extraction protocol; diet; NMR; extraction
1. Introduction
A certain lifestyle including a healthy diet is expected to be the key for long and healthy life.
However, many people in industrialized countries do not adhere to this kind of lifestyle and in
consequence suffer from metabolic disorders such as obesity, type II diabetes, and cardiovascular
disease [1,2]. Understanding the mechanisms of food metabolism by the gut and its microbial
inhabitants is a key to identify links between diet and health. The recent advances in metagenomics
have underlined the importance of a healthy intestinal microbial community (the microbiota)
for human health [3]. Certain food components are indigestible by the human intestine itself and thus
are available for microbial fermentation, which in turn produces metabolites, including vitamins [4].
Mostly, plant-derived carbohydrates commonly termed ‘dietary fiber’ reach the large intestine where
they serve as main substrate for microbial fermentation [5]. As reviewed recently [6], the resulting
short chain fatty acids (SCFA)—especially acetate, propionate and butyrate—are readily taken up by
the intestinal epithelium and serve as a main source of energy to the epithelial cells. Apart from that,
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SCFA may serve as signaling molecules affecting the body as a whole, e.g., by regulating satiety or
interfering with the immune system [6].
The protocol set presented in this work has been developed for the analysis of metabolites
from DIO mice fecal samples with a special focus on the quantification of SCFA due to their above
proposed role as signaling molecules by nuclear magnetic resonance (NMR) spectroscopy. The mouse
is an established model for the study of nutrition research and enables dietary intervention studies
for prolonged time [7,8]. Mice fecal samples are easily accessible and thus can be used to investigate
changes in the intestinal environment such as microbiota and metabolite profile throughout the whole
study period. For obesity studies high fat diets (HFD) are frequently used to generate diet induced
obesity (DIO) in mice.
Feces cannot be considered as uniform biological material. Bacteria comprise about 50% of
the total solids in human feces [9], but similarly to other components, microbiota composition mirrors
dietary as well as environmental or genetic effects. A number of publications has dealt with the impact
of different fecal extraction methods, focusing on metabolite coverage and integrity, taking into
consideration that bacterial activity and chemical degradation may affect sample stability (for review
see [10]). The gastrointestinal tract contains large amounts of both host proteases and bacterially
released proteases [11], parts of which are excreted in feces [12]. Yet, fecal protease activity has not
been extensively addressed in fecal metabolomics to our knowledge.
The majority of published NMR studies of feces typically uses phosphate buffer extraction,
which allows the extraction of the majority of water soluble metabolites [13–22]. When we apply
these protocols [13–23], we face sample stability problems over time, which were not reported in
the original publications. Suppression of bacterial activity by sodium azide does not solve the problem.
Thus we suspect strong enzymatic activity. Several approaches to modify the phosphate buffer
protocol to overcome this problem have been tried, but none of them has been sufficient (Figure 1).
Employing a mixed organic solvent with saline buffer finally solves the stability problem, however,
at the expense of an increased lipid background, which prevented the detection and proper integration
of the targeted SCFA in the spectra (as demonstrated in the Results Section in Figure 6).
Before describing the protocol, which addresses the above problems, specific NMR related
aspects have to be explained: NMR spectroscopy generally requires the use of deuterated (99.9%)
solvents as any protonated compound will strongly contribute to the signals in the spectra and could
potentially overlap with metabolite signals. Despite the fact that deuterated solvents have nowadays
considerably reduced prices, common (cheap) solvents are preferred for protocols suitable for
large studies. Thus, feces could be initially extracted with a non-deuterated solvent that is then
replaced (e.g., by lyophilisation) by an NMR compatible solvent. However, the high volatility of
SCFA (formate, acetate, propionate, and butyrate) impedes the use of a lyophilisation step and requires
an NMR compatible solvent directly for extraction.
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Figure 1. Proton nuclear magnetic resonance (NMR) spectra, which demonstrate changes in some of 
the metabolites extracted with phosphate buffer with extended storage at RT: (A) Mice fed on 
standard diet, (B) on high fat diet (HFD). 1 sample kept at 4 °C before measurement, 2 after 6 h, and 3 
after 24 h in the sample changer at RT. For clarity only the spectral region of interest, harboring 
resonances of the short chain fatty acid (SCFA), is shown. The red bar indicates the increased signal 
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Figure 1. Proton nuclear magnetic resonance (NMR) spectra, which demonstrate changes in some of
the metabolites extracted with phosphate buffer with extended storage at RT: (A) Mice fed on standard
diet, (B) on high fat diet (HFD). 1 sample kept at 4 ◦C before measurement, 2 after 6 h, and 3 after 24 h
in the sample changer at RT. For clarity only the spectral region of interest, harboring resonances of
the short chain fatty acid (SCFA), is shown. The red bar indicates the increased signal intensities.
Sample stability at room temperature is another critical issue as: (a) single mice feces sample can
weigh as little as 5 mg, w ich requires at least 30 min for NMR measurement at room tempe ature;
(b) samples are measured in an automat d mode using a sample changer, which often is not cooled.
Thus our go l is to achieve sample stability a r om temperature f minimum 6 h and if possible 24 h
to acquire the necessary quality of NMR spectra and efficiently use he measur ment time. In p st
projects on urine, serum or fish larvae samples [24–26] this was achi ved unless there w s a problem
with enzymatic and/ r bact rial activity. A summary of the performed test ex ractions is given in
Tables 1 and 2 and their outcome is described in d tail in the Results section.
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Table 1. Summary of the single-phase buffer extraction protocols used for the homogenized mice feces.
Protocol Freeze Cycle 1 Ultra-Sonication Details Reference
Basic 30 s vortex Wu [13]
ultrasonic 3 × 30 s kept at 4 ◦C, vortex in between Lamichhane [14]
Shock freeze 1 3 × 30 s vortex before freezing Lamichhane [14]
Combination of ultra-sonication
and shock freeze 1 3 × 30 s 3 × 30 s
kept to 4 ◦C
vortex in between the runs Lamichhane [14]
Double extraction, 1st fraction 3 × 30 s kept at 4 ◦C, vortex in between Wu [13]
Double extraction, 2nd fraction 3 × 30 s kept at 4 ◦C, vortex in between Wu [13]
Double extraction, fractions combined 3 × 30 s kept at 4
◦C, vortex in between,
lyophilised at −80 ◦C overnight Wu [13]
Beads ceramic beads 15 minby 99 rpm juddered
Acetonitrile
(10%, 20%, or 30%) 3 × 30 s
tempered to 4 ◦C
vortex in between
EDTA 2 mM EDTA, 30 s vortex
8.75 M TCA/buffer (1:34 v:v) 10 min incubation in fridge (6 ◦C)
Heating (40 ◦C, 60 ◦C or 90 ◦C) 10 min
Filter (10 kDa or 3 kDa) Supernatant 15 or 30 minat 15,000× g centrifuged
1 with liquid nitrogen.
Table 2. Summary of the two phase extraction protocols used for the homogenized mice feces.
Extraction Solvent 1 Centrifugation Details Reference
MeOD-d4/CDCl3/D2O
(or buffer 2)
300/300/350
(1:1:1.166)
30 min, 1400× g, 4 ◦C,
10 min 15,000× g, 4 ◦C,
each separate phase
Phase separation
overnight Lamichhane [14]
CD2Cl2/buffer
600/600
(1:1)
30 min 15,000× g, 4 ◦C,
aqueous phase
10 min 15,000× g, 4 ◦C
- -
0.15 M NaCl/CDCl3/MeOD-d4
600/400/200
(3:2:1) RT, 10 min, 1100× g - Kraus [27]
3
0.15 M NaCl/CDCl3/MeOD-d4
600/400/200
(3:2:1) 30 s vortex, 4
◦C, 10 min, 1100× g Optionally threeCDCl3 washing steps
Protocol 1,
this work
0.15 M NaCl/CDCl3/MeOD-d4
600/400/200
(3:2:1)
30 s vortex, homogenizer four times
20 s, 10 ◦C, 6000 rpm, centrifuged
0 ◦C 1485× g for 10 min
- Protocol 2,this work
1 The amounts of solvent are given in µL and as ratios in brackets; 2 buffer means phosphate buffer; 3 for extraction
of hydrophobic components using the chloroform phase.
2. Experimental Design
Mice in our study are fed either on a standard mice diet or a special diet (HFD) leading to
increased lipid content in the corresponding feces. To minimize sample variation, a homogenization
step mixing feces from different animals belonging to either the standard diet or the HFD group
is applied at the beginning to generate identical test samples (pooled samples) used as aliquots
throughout the manuscript. As the high fat diet leads to an increased amount of lipids in the mice
feces, their signals can potentially mask the signals of the SCFA and so special care has been applied to
take this into account. To generate test sample, feces have been thoroughly mixed by crushing them in
a mortar, aliquoted, and kept at −20 ◦C until the actual extraction.
To increase stability at room temperature over several hours, a two phase extraction protocol
is developed. An organic phase (deuterated) is added to the phosphate buffer. The clear phase
separation of the organic and aqueous phases allows us to measure both extraction layers and to
identify in which layer the desired SCFA is contained. The addition of organic solvents, however,
extracts significant amounts of lipids into the aqueous phase rendering SCFA signal integration
problematic, especially for HFD mice. In order to solve this problem, we have tried lipid background
removal according to Kraus et al. with the crucial difference that we are interested in the aqueous
and not the lipid containing organic phase [27].
As described in detail in the Results section, two versions of improved lipid extraction (LE)
procedures with and without washing steps (Protocol 1) and the lipid extraction with homogenizer
(Protocol 2) are developed. The two protocols perform equivalently in terms of removal of background
Metabolites 2019, 9, 55 5 of 19
signals and sample stability and which one is to be taken depends on the availability of a homogenizer.
They are schematically demonstrated in Figure 2 and step by step explained in the Procedure section.
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Figure 2. Schematic representation of the developed protocols for extraction of metabolites from mice
feces within this work (Protocol 1 and Protocol 2). Protocol 1 has optional washing steps for more
efficient lipid background removal. The difference of Protocol 2 with respect to Protocol 1 is the use
of homogenizer.
2.1. Materials
The mice feces originate exclusively from male C57Bl/6 mice purchased from Charles River
(Sulzfeld, Germany) at 8 weeks of age. All experimental procedures are approved by the according
authorities (regional council Karlsruhe regional council #35-9185.81/G-187/15) and carried out in
the Central Animal Facility of the Max Rubner-Institut Karlsruhe in accordance with the German animal
protection law. After one week of adaptation on a standard rodent chow, mice are fed on one of six
experimental HFD, supplemented with 10% of different grain fractions or cellulose. The biological study
investigates the influence of grain fractions on the development of nutrition based metabolic diseases
and will be published elsewhere. Therefore two different kinds of feces are used for the development
of this extraction protocol either from mice on standard rodent diet or on HFD. All the experimental
diets have been specifically prepared for this study by Ssniff Spezialdiäten GmbH, Soest, Germany.
All mice feces used within this manuscript have been randomly removed from the cages in the morning,
frozen directly at −20 ◦C, stored for period between 4 and 8 months and homogenized before extraction
by mortars as described in detail in the Procedure section. Thus these feces cannot be assigned to
a specific animal number.
In the extraction procedure with filters Amicon Ultra Centrifugal Filters with 3 kDa and 10 kDa
are used from Merck KGaA, Darmstadt, Germany.
The deuterated solvents are all obtained from Eurisotop GmbH. The deuterated water D2O has
isotopic purity >99.90%, solvent MeOD-d4 and CDCl3 and acetonitrile-d3 are with isotopic purity
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>99.80%. For the buffer chemicals from Sigma-Aldrich with purity >99% are used. 1.5 M phosphate
buffer is prepared from NaH2PO4/Na2HPO4, 20:80 D2O/H2O, 2mM TSP with pH adjusted to 7.40.
For the saline solution 0.15 mM NaCl, 20:80 D2O/H2O, 2mM TSP are used and pH adjusted to 7.40.
TSP is commonly used as a reference signal in NMR spectroscopy.
The chemicals used for extraction are as follows: NaH2PO4 (Sigma-Aldrich, Taufkirchen, Germany;
Cat. no.: 71507-MM); Na2HPO4 (Sigma-Aldrich, Taufkirchen, Germany; Cat. no.: 71645-1KG); D2O
(Eurisotop, Saarbrücken, Germany; Cat. no.: D214L); H2O: Millipore-Q biocel Adavantage A10
Merck KGaA Darmstadt, Germany; CDCl3 (Eurisotop, Saarbrücken, Germany; Cat. no.: D006H);
TSP (Sigma-Aldrich, Taufkirchen, Germany; Cat. no.: 269913-1G); Acetonitrile-d3 (Eurisotop,
Saarbrücken, Germany; Cat. no.: D021FE); MeOD-d4 (Eurisotop, Saarbrücken, Germany; Cat. no.: D021FE);
EDTA (Sigma-Aldrich, Taufkirchen, Germany; Cat. no.: 798681-100G); NaN3 (Sigma-Aldrich,
Taufkirchen, Germany; Cat. no.: S2002-25G); trichloroacetic acid (Sigma-Aldrich, Taufkirchen, Germany;
Cat. no.: T6399-100G).
2.2. Equipment
Centrifuges: Eppendorf Centrifuge 5418 (Eppendorf AG, Hamburg, Germany), and Perfect Spin 24R
(PEQLAB Biotechnologie GmbH, Erlangen, Germany)
Vortex: Mixer Vortex Genie 2 (Scientific Industries Inc., Bohemia, NY, USA) and Rotator with
vortex RM–2M (neoLab Migge GmbH, Heidelberg, Germany)
Ultra-sonic bath: FB 15047 (Fisher Scientific International Inc., Pittsburgh, PA, USA)
Homogenizer: Precellys Evolution Homogenizer (Berting GmbH, Frankfurt (Main), Germany)
with Cryolys Cooling Option (Berting GmbH, Frankfurt (Main), Germany) and Precellys Lysing KITS
(Berting GmbH, Frankfurt (Main), Germany; Cat. no.: CK 14).
NMR measurements: The NMR experiments are performed with a Bruker Avance II+ 600 MHz
spectrometer (Bruker Biospin GmbH, Rheinstetten, Germany) equipped with a 5 mm room temperature
BBI probe head with actively shielded z-gradients. The proton frequency of the used spectrometer is
set to 600.193 MHz. The temperature stability is controlled via a Bruker BVT unit and is calibrated to
be exactly 300 K. One dimensional proton experiments with water suppression are measured with
the Bruker standard pulse sequence “noesygppr1D” for 1D NOESY experiment with water suppression
and mixing time of 10 ms. The parameters used are as follows: 256 repetitions, four dummy scans,
and a receiver gain set to 90.5. In some cases, additional experiments with Bruker standard pulse
sequences “cpmgpr1D” and “jresgpprqf” are performed using standard parameters.
3. Procedure
Time for Completion: Typically the Time for Completion Including Buffer Preparation Is 3:00 Hours.
Both protocols aim at an efficient and reproducible extraction of SCFA and other untargeted
metabolites for NMR metabolomics studies, where long term (at least 24 h) stability at room
temperature was targeted (in our case 20 ◦C). Both protocols use 20 mg homogenized mice feces.
The fecal samples are frozen immediately after collection and stored at −20 ◦C until the extraction.
The 0.15 M sodium chloride solution as described in the Materials section contains 20% D2O for
the NMR lock system and 2mM TSP as a standard reference signal. The pH of the feces extracts is
basic and depending on the origin (standard mice diet or HFD) varies between 7.9 and 8.1 pH.
Protocol 1: Lipid Extraction (LE) Using Optional Washing Steps with Chloroform
1) Weigh 20 mg of the homogenized mouse feces into micro centrifuge tube. Unless otherwise
specified and as far as possible, during all the waiting periods keep the samples on dry ice.
2) Add 600 µL of 0.15 M sodium chloride to the tube. Add additional 600 µL of CDCl3/MeOD-d4
(2:1, v/v). Then vortex the mixture for 30 s.
3) Place the micro centrifuge tube at 4 ◦C for the extraction period for 10 min.
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4) Centrifuge the suspension for 10 min at 1100× g and 4 ◦C.
5) Transfer the aqueous phase to a new micro centrifuge tube for the washing procedure.
Critical Step: A critical step in this protocol is the separation of the two layers and pipetting of
the aqueous phase (upper layer) from the organic phase (lower layer). The phase separation between
the layers is very thin and contains residues of the mouse droppings. Thus it is easy to pierce into
the organic phase and pipette together with the aqueous phase so that some of the organic layer could
be transferred to the NMR tube.
6) Add 200 µL of CDCl3 to the aqueous phase.
7) Centrifuge the suspension for 2 min at 1100× g at 4 ◦C.
8) Take the chloroform layer away and add fresh amount of 200 µL of CDCl3 to the aqueous phase.
Repeat the centrifugation step 7.
9) Take the chloroform layer again away and add fresh amount of 200 µL of CDCl3 to
the aqueous phase.
10) Perform the third centrifugation for 10 min at 1100× g at 4 ◦C.
11) Take the chloroform layer again away. Optional Steps: The described steps from number 5 till 10
are optional. We have realized that these steps help removing the lipid content in our samples
originating from mice fed on HFD. However, these steps could only be recommended when no
additional small molecular sized metabolites could be also washed out in the process. This should
be checked on the samples of interest. Alternatively, the number of washing steps could be
reduced to either merely one or two instead of the tested three steps.
12) Transfer 500 µL of the aqueous phase to an NMR tube, add NaN3 with 1.5 mmol/L concentration
and measure the sample by NMR.
Protocol 2: Lipid Extraction Using a Homogenizer
1) Weigh 20 mg of the homogenized mouse feces into the lysing kit tube CK 14 without beads.
2) Add about 8 ceramic beads (one full spatula) to the solid feces material.
3) Add 600 µL of 0.15 M sodium chloride to the tube. Additionally add 600 µL of CDCl3/MeOD-d4
(2:1, v/v).
4) Vortex the suspension for 30 s.
5) Seal the tube and homogenize it with a Precellys homogenizer. Perform four homogenization
cycles at 6000 rpm at 10 ◦C. Each cycle lasts 20 s and is followed by a waiting time of 120 s
at 10 ◦C.
Critical Step: A critical step in this protocol is the separation of the two layers and pipetting of
the aqueous phase (upper layer) from the organic phase (lower layer). The phase separation between
the layers is very thin and contains residues of the mouse droppings. Thus it is easy to pierce into
the organic phase and pipette together with the aqueous phase so that some of the organic layer could
be transferred in the NMR tube.
6) Transfer the suspension to a new micro centrifuge tube and centrifuge for 10 min at 1485× g
and 0 ◦C.
7) Transfer 500 µL of the aqueous phase to a NMR tube, mix it with NaN3 with 1.5 mmol/L
concentration and measure it by NMR.
Pause Step: Protocol 1 and 2 do not allow pause step within the extraction procedure. A possible
pause could be performed after the aqueous phase has been transferred to the NMR tube and sodium
azide is added. Then the NMR tubes could be stored on dry ice.
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4. Results
Following the various phosphate buffer based extraction procedures, summarized in Tables 1
and 2 [13,14], we have observed changes over time in some metabolites. In the Results section
we describe the tested procedures, including the application of the protocol set developed within this
manuscript and their outcome. Based on the fact that the two phase extraction protocol efficiently
suppresses the changes over time, detectable by NMR spectroscopy, the changes are attributed to
enzymatic activity.
The basic extraction protocol from the literature ([13,14] and references therein) comprises addition
of buffer (700 µL) to the homogenized feces (20 mg), short vortexing followed by a centrifugation
step, and transfer of the supernatant to a 5 mm NMR tube. The basic protocol is extended with
various ultra-sonication steps [14], and/or freeze-thaw cycles with liquid nitrogen (shock freeze) [14],
double extraction on the same feces amounts [13], and the addition of beads as beads allow efficient
homogenization. A comparison of these extraction methods analyzed by NMR spectra is shown
in Figures S1 and S2. Sample stability problems using these protocols have manifested themselves
in an increase over the time of several amino acids’ peak intensities. As demonstrated in Figure 1,
changes are observed for e.g., alanine (1.48 ppm, doublet (d)), threonine (1.33 ppm, d), valine (0.99 ppm,
d, 1.05 ppm, d), leucine (0.96 ppm, d, 0.97 ppm, d), and isoleucine (0.94 ppm, t, 1.01 ppm, d). In addition
to the increased amino acids, a decrease of UDP-glucose (5.62 ppm, dd, 6.00 ppm, d) can be observed.
These changes are already detected in an immediate repetition of the measurement. Thus stability is
less than 70 min, because 35 min are the minimum NMR measurement time per sample and we cannot
even guarantee stability within the first measurement. After 24 h the two signals for the UDP-glucose
and other signals between 5.50 and 6.20 ppm have disappeared completely (Figure 3). The latter
changes most probably stem from bacterial activity as this problem could be solved by the addition of
sodium azide (1.5 mmol/L). All following preparations always contain sodium azide. The original
changes in amino acids are attributed to enzymatic activity (Figure 1).
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The addition of 20% deuterated acetonitrile slows down but does not fully prevent enzymatic
activity over 24 h. Addition of 30% (or higher amounts of) acetonitrile causes measurement
problems due to the presence of a second deuterated solvent, which prevents automatic measurement.
As additional drawback, signals show severe line broadening and accurate integration is not possible
(Figure 4). Protein denaturation by pH change, addition of TCA or EDTA is not successful to suppress
enzymatic activity. Heating to 60 ◦C for 10 min results in both an increase of the background signals
(Figure S3) and still shows residual enzymatic activity after 5 h. Heating to 90 ◦C for 10 min shows
sample stability for more than a day, but increased strong background signals of protein and/or lipids
prevents proper integration and risks loss of the volatile SCFA.M taboli es 2019, 9, x 10 of 20 
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(approximately 16 h), which makes it impractical for studies with large number of samples. An 
extraction with cold methanol only is completely inefficient (Figure S4). 
Figure 4. Effect of extraction ith different concentrations of acetonitrile on the etabolite signals:
(A) feces of mice fed on a standard diet and (B) on a HFD diet. For clarity only a selected spectral range
of the proton NMR spectra is shown. Please note that the increased amount of acetonitrile induces
chemical shifts on the signal resonances.
The two phase protocol with a mixed MeOD-d4/CDCl3/phosphate buffer according to [14]
extracts SCFA metabolites in the aqueous phase. This shows no bacterial and enzymatic activity
over time (up to 24 h). The exchange of chloroform to dichloromethane leads to similar results,
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whereas omission of chloroform during extraction leads to an increase in lipid background (Figure 5).
As depicted in Figure 5, the SCFA signals have lower intensity on an increased lipid background.
This overlap causes integration problems. When comparing the intensity of the extracted butyrate with
the basic protocol and the two phase extraction, it becomes clear that butyrate is so highly overlapped
that it becomes undetectable with the two phase extraction protocol. In addition, the presence of
more than one deuterated solvent (CDCl3, MeOH-d4, and D2O) leads to random lock switches in
the automatic measurements and consequently to severe problems in water suppression and arbitrary
settings of the chemical shift scale. An additional drawback of this protocol is the long preparation
period of about 24 h in total, including storage step in a refrigerator overnight (approximately 16 h),
which makes it impractical for studies with large number of samples. An extraction with cold methanol
only is completely inefficient (Figure S4).Metabolites 2019, 9, x 11 of 20 
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To overcome the problem with increased lipid background and eventually reduced
SCFA extraction, we have looked for procedures to shift the lipid extraction completely to the organic
phase. A suitable protocol is found in Kraus et al. [27]. A comparison of the NMR spectra from this
protocol (sodium chloride and a mixed solvent of chloroform and methanol) with phosphate buffer
extraction shows both increased amounts of SCFA and the desired stability of the samples over time
(Figure 6). The drawback of this protocol is again increased background, originating from lipids
and probably steroids, in the aqueous phase, thus for further optimization the influence of temperature
is evaluated. Extraction and the centrifugation step after vortexing are tested at either −20 ◦C, 4 ◦C,
or +20 ◦C (Figure 7). In order to achieve better and clearer phase separation increased centrifugation
speed up to 11,000× g is also evaluated, but has no positive influence. The optimum result is obtained
when extraction and centrifugation steps are performed at 4 ◦C (see Figure 7). Increased amounts of
the SCFA could be obtained in this way with concomitant reduction in lipid background. Protocol 1
(a) shows the suppression of the enzymatic activity; (b) allows extraction of maximum amounts
of metabolites; (c) the contribution of background signals is kept to minimum and (d) it performs
equivalently well for feces with different fat composition, e.g., mice on standard diet and HFD.
As the application of this protocol allows fulfilling all the requirements, we have evaluated its
performance by comparing the NMR spectra of the two phases. After phase separation, the chloroform
phase is measured and plotted against the aqueous phase (Figure S5). It confirms our expectation that
lipids would predominantly reside in this phase.
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is tried (Protocol 2). Th feces together with the solvents are p ac d int Precellys tubes with
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i created. For these peaks the r spec ive bucke table is generated in Amix. Thus in the bucket table
each signal is represe ted as a s parate bin and it can e compared with the s me spectral pieces
from the other NMR measurements. The bucket table is afterwards used for statistical evaluation
(princip compone t analysis, PCA) of the observed variations in the NMR spectra over tim using
the online MetaboAnalyst packag [28–31]. Range scaling is applied to each bin prior to the statistical
analysis, which n ure that ll bins are treated equally [32,33]. The explained variation with the PC1
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is 95.4% is as expected due to the differences based on the diet. The remaining 2.6% variation on
the PC2, as it can be seen in the resulting PCA scores plot (Figure 9) demonstrates the minimal
variation observed on the same sample over time at RT. To some extend these minor variations in
the consecutive NMR measurements can be attributed to the performance of the automated field
homogeneity routine, leading to line broadening in the observed resonances. This result clearly
indicates that the extracted solution using the protocol set presented in this manuscript does not show
significant changes (neither chemical degradation, nor enzymatic activity) in the NMR spectra when
stored at room temperature up to 24 h.
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As a final option, we have used filters with a suitable cut off molecular size to separate the signals
from high molecular weight lipid and proteins compounds (3 kDa and 10 kDa). The 3 kDa filter shows
increased intensity for the signal at 1.33 ppm (Figure 12), either lactate or threonine. This could be
due to the increased time because of the centrifugation step during which the proteases can be active.
Samples prepared with a filter centrifugation step have no changes after 20 h, while 10 kDa filters
allow more than 4 days stability. With this approach, the best performance is achieved compared to all
previously tested approaches. Nevertheless, one drawback of this filtering approach concerns butyrate
(0.82 ppm, t) as there is remaining background signal (Figure 12). The thereby introduced integration
Metabolites 2019, 9, 55 16 of 19
error is non-systematic and will lead to improper statistical evaluation of the NMR spectra. We have
restrained ourselves from using the filters as they cannot be reused, are relatively expensive and thus
are not the first choice for studies with more than 300 samples.
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e have adapted Protocol 1 for those labs where a homogenizer is available and referred to it
as Protocol 2. As it can be seen in Figure 5 and in Figures S6, Figures 10 and 11, Protocol 1 without
the optional washing steps and Protocol 2 (with homogenizer) lead to practically overlapping spectra
for both mice feces types. The use of a homogenizer leads to less and simpler steps and extracts
a aximum amount of SCFA with minimal background disturbance in an efficient and easy way.
As additional safety precaution to overcome the initial problem with bacterial activity,
sample storage should avoid unnecessary periods at RT. Probably storage at −20 ◦C is not sufficient.
An optimal procedure in our lab is immediate shock freeze by liquid nitrogen with following storage
at −80 ◦C. The protocol versions presented in this manuscript (Protocol 1 and 2) with or without
the optional washing steps allow sample storage after extraction for 24 h. They are cost efficient as they
do not require the use of too expensive consumables. The two phase extraction allows the suppression
of undesired enzymatic activity and they are suitable for measurements of the typical number of
hundreds to thousands of samples in metabolomics studies.
l t Materials: The following are available online at http://www.mdpi.com/2218-1989/9/3/55/s :
Figure S1: Comparis n spectra of the xtracted metabolites using ultra-sonication and/or shock freeze f r
extraction of mice feces on a standard diet. For clarity only the spectral region of interest, harbouring resonances of
the short chain fatty acid (SCFA) is shown, Figure S2: Comparison spectra of the extracted metabolites using single
extraction steps and their combination, where first and second extraction is performed on mice feces on a standard
diet and the combined phase of the extractions after lyophilisation is given. For clarity only the spectral region of
interest, harbouring resonances of the SCFA is shown. Figure S3. Evaluation of the influence of the temperatur
on the recorded NMR spectra, where in green i the spectrum with the phosphate buffer extraction at room
temperature, blue with heating to 40 ◦C, 60 ◦C (violet), and 90 ◦C (red) colour. Figure S4. Comparison of
the methanol extraction applied to feces from mice on standard diet, where the signal intensities in the spectrum are
scaled down eight times, and from mice on high fat diet. Figure S5. Comparison of the metabolites in the aqueous
and chloroform phases originating from optimised protocol for lipid extraction, referred to as Protocol 1. Figure S6.
Comparison of Protocol 1 an 2 with t e basic protocol with shock freeze: (A) f ces of mice fed n a standard diet
and (B) on h gh fat diet (HFD) (the intensity is upscaled four times). F r clarity only a selected spectral range
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(0.6 ppm till 2.0 ppm) of the proton NMR spectra is shown and the most prominent metabolites are assigned.
Protocol 1 and 2 clearly extract more efficiently the SCFA, based on their increased intensity for both diets. Figure S7.
1H NMR spectrumof the extracted metabolites from mice on a standard diet with phosphate buffer protocol with
shock freeze. Figure S8. 1H NMR spectrumof the extracted metabolites from mice on a HFD with phosphate
buffer protocol with shock freeze Figure S9. 1H NMR spectrumof the extracted metabolites from mice on a HFD
with ultrafiltration (3kDa cut off filter). Figure S10. 1H NMR spectrumof the extracted metabolites from mice on
a standard diet with Protocol 1 without washing steps. Figure S11. 1H NMR spectrumof the extracted metabolites
from mice on a HFD with Protocol 1 without washing steps. Figure S12. 1H NMR spectrumof the extracted
metabolites from mice on a standard diet with Protocol 2. Figure S13. 1H NMR spectrumof the extracted
metabolites from mice on HFD with Protocol 2.
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